These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33242330)

  • 1. Catch those antibodies before they fall.
    Shaz BH; Cohn CS
    Blood; 2020 Nov; 136(22):2489-2490. PubMed ID: 33242330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with COVID-19 convalescent plasma provides vital guidance to future pandemics.
    Hartmann J; Bloch EM; Burnouf T
    Transfusion; 2022 Mar; 62(3):681-684. PubMed ID: 35098540
    [No Abstract]   [Full Text] [Related]  

  • 3. Donating convalescent plasma for COVID-19 patients.
    Black E
    Br Dent J; 2020 Nov; 229(10):643. PubMed ID: 33247247
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
    Casadevall A; Henderson JP; Joyner MJ; Pirofski LA
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621214
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulatory challenges of convalescent plasma collection during the evolving stages of COVID-19 pandemic in the United States.
    Hassan S; West KA; Conry-Cantilena K; De Giorgi V
    Transfusion; 2022 Feb; 62(2):483-492. PubMed ID: 34778974
    [No Abstract]   [Full Text] [Related]  

  • 6. New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic.
    Seghatchian J
    Transfus Apher Sci; 2021 Feb; 60(1):103051. PubMed ID: 33461918
    [No Abstract]   [Full Text] [Related]  

  • 7. Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Farag YMK
    Mayo Clin Proc; 2020 Dec; 95(12):2801-2802. PubMed ID: 33276848
    [No Abstract]   [Full Text] [Related]  

  • 8. In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.
    Joyner MJ; Senefeld JW; Klassen SA; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2020 Dec; 95(12):2802-2803. PubMed ID: 33276849
    [No Abstract]   [Full Text] [Related]  

  • 9. Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.
    Garraud O; Burnouf T
    Transfus Clin Biol; 2021 Aug; 28(3):225-227. PubMed ID: 34362557
    [No Abstract]   [Full Text] [Related]  

  • 10. Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
    Rubin EJ; Baden LR; Lee TH; Morrissey S
    N Engl J Med; 2021 Jan; 384(1):e13. PubMed ID: 33406335
    [No Abstract]   [Full Text] [Related]  

  • 11. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma.
    Tonn T; Corman VM; Johnsen M; Richter A; Rodionov RN; Drosten C; Bornstein SR
    Lancet Microbe; 2020 Jun; 1(2):e63. PubMed ID: 32835332
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin.
    Volk A; Covini-Souris C; Kuehnel D; De Mey C; Römisch J; Schmidt T
    BioDrugs; 2022 Jan; 36(1):41-53. PubMed ID: 34843105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of anti-SARS-CoV-2 antibodies in repeat convalescent plasma donors.
    Franchini M; Glingani C; Liumbruno GM; Mengoli C
    Transfus Apher Sci; 2021 Dec; 60(6):103216. PubMed ID: 34315677
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent plasma to deliver therapeutic antibodies against COVID-19.
    Senefeld JW; Casadevall A; Joyner MJ
    Trends Mol Med; 2022 May; 28(5):435-436. PubMed ID: 35248476
    [No Abstract]   [Full Text] [Related]  

  • 15. Convalescent plasma for SARS-CoV-2 infection: win or learn.
    Contreras-Barbeta E; Millan A; Rello J
    Eur Respir J; 2022 Feb; 59(2):. PubMed ID: 34531275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convalescent plasma for administration of passive antibodies against viral agents.
    Di Minno G; Mannucci PM; Ironside JW; Perno CF; Gürtler L; Aledort L
    Haematologica; 2020 Dec; 105(12):2710-2715. PubMed ID: 33256373
    [No Abstract]   [Full Text] [Related]  

  • 17. [COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].
    Richier Q; Hueso T; Tiberghien P; Lacombe K
    Rev Med Interne; 2023 Sep; 44(9):467-471. PubMed ID: 37689526
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid recovery of taste and smell in a patient with SARS-CoV-2 following convalescent plasma therapy.
    Fisher DL; Pavel A; Malnick S
    QJM; 2021 Aug; 114(5):319-320. PubMed ID: 33416888
    [No Abstract]   [Full Text] [Related]  

  • 19. Rethinking the role of COVID-19 convalescent plasma in the critically ill.
    Casadevall A; Pirofski LA
    Transfus Apher Sci; 2023 Feb; 62(1):103521. PubMed ID: 35941021
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of convalescent plasma in the therapy of COVID-19].
    Körper S; Seifried E; Schrezenmeier H
    Dtsch Med Wochenschr; 2023 Mar; 148(7):423-426. PubMed ID: 36940693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.